Delivery Order SPE2DB22D3501-SPE2DB25FVD14

Award Date 4/1/25
Potential Completion Date 4/2/25
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,188,368 units of Nateglinide 60 mg tablets. The contract has a ceiling value of $3,385.38 and an ultimate completion date of October 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,675.22 firm-fixed-price delivery order is for the supply of 4,566,177,969 units of the medication Nateglinide 120 mg Tablet UD 30s. The contract has an ultimate completion date of October 23, 2024 and was awarded on October 22, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,555,719,952 tablets of the drug Nateglinide 60 mg. The contract has a completion date of December 16, 2021 and a potential value of $13,114.83. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA with a potential value of $999,999,999.00 through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,037.49 firm fixed-price delivery order is for the supply of 4,566,825,872 units of the drug Nateglinide 120 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order for the supply of 4,567,074 units of Nateglinide 120 mg tablets to the agency. The contract has a total ceiling value of $15,880.84 and is a firm fixed-price arrangement. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award, valued at $1,842.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,875,756 units of the medication Nateglinide 60 mg Tablet in 100-count packages. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of April 11, 2025. It is not designated as a set-aside contract,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $6,635.81, is for the delivery of 4567707676 ! NATEGLINIDE 120 MG TABLET UD 30S. It is a firm fixed-price delivery order contract that will run through March 27, 2025. The contract is not set aside for any specific business type. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $3,372.95 for the supply of 4564766054 NATEGLINIDE 60 MG TABLET UD 30S. The contract has a firm-fixed price pricing type and an ultimate completion date of June 3, 2024. Amerisourcebergen is a for-profit corporate entity that specializes in distributing a comprehensive range of...
This federal contract award, valued at $1,139.17, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract provides for the delivery of 4564824221 NATEGLINIDE 60 MG TABLET UD 30S, a prescription drug product, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of June 7, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical for the procurement of pharmaceutical products, including a tablet medication. The contract has a ceiling value of $13,929.10 and a completion date of January 13, 2025. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FVD14
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Nateglinide 60 mg tablets. The contract has a ceiling value of $4,166.99 and runs through April 2, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition.

AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 7/1/25, 9:59 AM